IL210504A0 - Genetic variants for breast cancer risk assessment - Google Patents
Genetic variants for breast cancer risk assessmentInfo
- Publication number
- IL210504A0 IL210504A0 IL210504A IL21050411A IL210504A0 IL 210504 A0 IL210504 A0 IL 210504A0 IL 210504 A IL210504 A IL 210504A IL 21050411 A IL21050411 A IL 21050411A IL 210504 A0 IL210504 A0 IL 210504A0
- Authority
- IL
- Israel
- Prior art keywords
- breast cancer
- risk assessment
- genetic variants
- cancer risk
- genetic
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 238000012502 risk assessment Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/60—In silico combinatorial chemistry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Library & Information Science (AREA)
- Computing Systems (AREA)
- Crystallography & Structural Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS8746 | 2008-07-07 | ||
| PCT/IS2009/000008 WO2010004591A2 (en) | 2008-07-07 | 2009-07-03 | Genetic variants for breast cancer risk assessment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL210504A0 true IL210504A0 (en) | 2011-03-31 |
Family
ID=41110719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL210504A IL210504A0 (en) | 2008-07-07 | 2011-01-06 | Genetic variants for breast cancer risk assessment |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8951735B2 (enExample) |
| EP (1) | EP2313525A2 (enExample) |
| JP (1) | JP2011527565A (enExample) |
| KR (1) | KR20110036608A (enExample) |
| CN (1) | CN102144036B (enExample) |
| AU (1) | AU2009269542A1 (enExample) |
| CA (1) | CA2729934A1 (enExample) |
| IL (1) | IL210504A0 (enExample) |
| NZ (1) | NZ590833A (enExample) |
| WO (1) | WO2010004591A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011095999A1 (en) * | 2010-02-05 | 2011-08-11 | Decode Genetics Ehf | Genetic variants for predicting risk of breast cancer |
| EP2721180A4 (en) * | 2011-06-16 | 2015-09-02 | Decode Genetics Ehf | GENETIC VARIANTS FOR PREDICTING THE RISK OF BREAST CANCER |
| CN102643905B (zh) * | 2012-04-01 | 2014-06-11 | 周宏灏 | 焦磷酸测序法检测他莫昔芬个体化用药基因多态性的试剂盒及方法 |
| KR101770962B1 (ko) * | 2013-02-01 | 2017-08-24 | 에스케이텔레콤 주식회사 | 유전자 서열 기반 개인 마커에 관한 정보를 제공하는 방법 및 이를 이용한 장치 |
| WO2014119914A1 (ko) * | 2013-02-01 | 2014-08-07 | 에스케이텔레콤 주식회사 | 유전자 서열 기반 개인 마커에 관한 정보를 제공하는 방법 및 이를 이용한 장치 |
| WO2014145705A2 (en) | 2013-03-15 | 2014-09-18 | Battelle Memorial Institute | Progression analytics system |
| CN103981273B (zh) * | 2014-05-30 | 2017-01-18 | 复旦大学附属肿瘤医院 | 一组评估乳腺癌风险的突变基因群及其检测试剂盒 |
| US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
| CN105069322B (zh) * | 2015-07-24 | 2018-01-12 | 上海尔云信息科技有限公司 | 疾病易感风险预测装置 |
| CN109074426B (zh) | 2016-02-12 | 2022-07-26 | 瑞泽恩制药公司 | 用于检测异常核型的方法和系统 |
| CN105586427B (zh) * | 2016-03-10 | 2020-06-19 | 厦门艾德生物医药科技股份有限公司 | 检测人类brca1和brca2基因突变的引物、试剂盒及方法 |
| US11332530B2 (en) | 2016-09-23 | 2022-05-17 | Memorial Sloan Kettering Cancer Center | Determinants of cancer response to immunotherapy |
| CN106676169B (zh) * | 2016-11-15 | 2021-01-12 | 上海派森诺医学检验所有限公司 | 一种用于乳腺癌易感基因brca1和brca2突变检测的杂交捕获试剂盒及其方法 |
| CA3051488A1 (en) * | 2017-01-24 | 2018-08-02 | Genetic Technologies Limited | Improved methods for assessing risk of developing breast cancer |
| CN107341347A (zh) * | 2017-06-27 | 2017-11-10 | 天方创新（北京）信息技术有限公司 | 基于评分模型对乳腺癌进行风险评分的方法及装置 |
| EP3814521A4 (en) * | 2018-06-29 | 2022-07-27 | The Jackson Laboratory | SPLICING VARIANTS FOR BREAST CANCER |
| CN108676890B (zh) * | 2018-07-12 | 2022-01-28 | 吉林大学 | 一种女性乳腺恶性肿瘤易感性预测试剂盒及系统 |
| US20230170045A1 (en) * | 2020-04-20 | 2023-06-01 | Myriad Genetics, Inc. | Comprehensive polygenic risk prediction for breast cancer |
| WO2024085660A1 (ko) * | 2022-10-18 | 2024-04-25 | 제노플랜 인크 | 질병 발생 위험도 예측 장치 및 방법 |
| WO2024148280A1 (en) | 2023-01-06 | 2024-07-11 | Ideaya Biosciences, Inc. | Treatment of er+ breast cancer comprising homologous recombination deficiency using parc inhibitor |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| EP1997891A1 (en) | 1988-09-02 | 2008-12-03 | Dyax Corporation | Generation and selection of recombinant varied binding proteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| AU665190B2 (en) | 1990-07-10 | 1995-12-21 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| WO1992009690A2 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with altered binding properties |
| ATE439435T1 (de) | 1991-03-01 | 2009-08-15 | Dyax Corp | Chimäres protein mit mikroprotein mit zwei oder mehr disulfidbindungen und ausgestaltungen davon |
| DE69233750D1 (de) | 1991-04-10 | 2009-01-02 | Scripps Research Inst | Bibliotheken heterodimerer Rezeptoren mittels Phagemiden |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| EP0695941B1 (en) | 1994-06-08 | 2002-07-31 | Affymetrix, Inc. | Method and apparatus for packaging a chip |
| US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
| EP2369007B1 (en) | 1996-05-29 | 2015-07-29 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
| US20040009481A1 (en) * | 2001-06-11 | 2004-01-15 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer |
| DE10228081A1 (de) * | 2002-06-18 | 2004-01-08 | InViTek Gesellschaft für Biotechnik & Biodesign mbH | Verfahren zum Nachweis einer gesteigerten Tumorsuszeptibilität |
| KR100763902B1 (ko) * | 2004-02-20 | 2007-10-05 | 삼성전자주식회사 | 유방암 특이적 단백질, 그를 코딩하는 유전자, 및 상기단백질 또는 유전자를 이용한 유방암의 진단 방법 |
| WO2006063285A2 (en) * | 2004-12-10 | 2006-06-15 | Sequenom, Inc. | Methods for identifying risk of breast cancer or prostate cancer and treatments thereof |
| CN101037690B (zh) * | 2006-03-16 | 2011-07-20 | 国家人口计生委科学技术研究所 | 具有新的单核苷酸多态性的brca1基因变体和其编码的蛋白质变体 |
| EP2089548A1 (en) * | 2006-10-27 | 2009-08-19 | Decode Genetics EHF | Cancer susceptibility variants on chr8q24.21 |
| CN101874120B (zh) | 2007-03-26 | 2015-01-14 | 解码遗传学私营有限责任公司 | 作为用于乳腺癌风险评估、诊断、预后和治疗的标记的chr2和chr16的遗传性变型 |
| EP2164984A2 (en) | 2007-05-25 | 2010-03-24 | Decode Genetics EHF. | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
-
2009
- 2009-07-03 AU AU2009269542A patent/AU2009269542A1/en not_active Abandoned
- 2009-07-03 JP JP2011517318A patent/JP2011527565A/ja active Pending
- 2009-07-03 KR KR1020117002889A patent/KR20110036608A/ko not_active Ceased
- 2009-07-03 EP EP09787620A patent/EP2313525A2/en not_active Withdrawn
- 2009-07-03 WO PCT/IS2009/000008 patent/WO2010004591A2/en not_active Ceased
- 2009-07-03 CA CA2729934A patent/CA2729934A1/en not_active Abandoned
- 2009-07-03 CN CN200980134453.0A patent/CN102144036B/zh not_active Expired - Fee Related
- 2009-07-03 NZ NZ590833A patent/NZ590833A/xx not_active IP Right Cessation
- 2009-07-03 US US13/002,619 patent/US8951735B2/en not_active Expired - Fee Related
-
2011
- 2011-01-06 IL IL210504A patent/IL210504A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2313525A2 (en) | 2011-04-27 |
| AU2009269542A1 (en) | 2010-01-14 |
| US20110294673A1 (en) | 2011-12-01 |
| WO2010004591A2 (en) | 2010-01-14 |
| JP2011527565A (ja) | 2011-11-04 |
| WO2010004591A3 (en) | 2010-03-18 |
| CA2729934A1 (en) | 2010-01-14 |
| CN102144036A (zh) | 2011-08-03 |
| KR20110036608A (ko) | 2011-04-07 |
| CN102144036B (zh) | 2014-07-16 |
| NZ590833A (en) | 2013-01-25 |
| US8951735B2 (en) | 2015-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL210504A0 (en) | Genetic variants for breast cancer risk assessment | |
| IL216627A0 (en) | Methods for breast cancer risk assessment | |
| EP2385989A4 (en) | GENETIC VARIANTS FOR THE RISK ASSESSMENT OF THYROID CANCER | |
| IL211177A0 (en) | Genetic variants useful for risk assessment of thyroid cancer | |
| IL212905A0 (en) | Individualized cancer dignosis | |
| IL218118A0 (en) | Target genes for cancer therapy | |
| EP2275135A4 (en) | THERAPY FOR HEPATIC CANCER | |
| ZA201108118B (en) | Treatment regimin utilizing neratinib for breast cancer | |
| GB0800702D0 (en) | Genes | |
| EP2507396A4 (en) | MULTI-MEDICATION RESPONSE MARKERS FOR BREAST CANCER CELLS | |
| EP2460516A4 (en) | LIPID NANOPARTICLES FOR GENE THERAPY | |
| GB0804496D0 (en) | Treating cancer | |
| GB0918722D0 (en) | Anti cancer agent | |
| ZA201202169B (en) | Targeting pax2 for the treatment of breast cancer | |
| ZA201104932B (en) | Phenylimidazole compounds | |
| GB0910751D0 (en) | Prostate cancer vaccine | |
| GB0921088D0 (en) | Prostate Cancer DNA Vaccine | |
| EP2321641A4 (en) | GENE METHYLATION IN THE DIAGNOSIS OF CANCER | |
| GB0707556D0 (en) | Treatment for cancer | |
| EP2473613A4 (en) | KREBSAUSHUNGERUNGSTHERAPIE | |
| ZA201201894B (en) | Pharmaceutical combination for treating tumor | |
| GB0809046D0 (en) | Cancer treatment | |
| HK1157403A (en) | Genetic variants for breast cancer risk assessment | |
| GB0808116D0 (en) | bioarker for pancreatic cancer | |
| GB0913603D0 (en) | Cancer therapy |